These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37226800)

  • 21. Aminosulf(ox)ides as ligands for Iridium(I)-catalyzed asymmetric transfer hydrogenation.
    Petra DG; Kamer PC; Spek AL; Schoemaker HE; van Leeuwen PW
    J Org Chem; 2000 May; 65(10):3010-7. PubMed ID: 10814191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iridium-catalyzed chemoselective asymmetric hydrogenation of conjugated enones with ferrocene-based multidentate phosphine ligands.
    Ma J; Li W; He L; Lv H
    Chem Commun (Camb); 2022 May; 58(39):5841-5844. PubMed ID: 35466969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperative catalysis: combining an achiral metal catalyst with a chiral Brønsted acid enables highly enantioselective hydrogenation of imines.
    Tang W; Johnston S; Li C; Iggo JA; Bacsa J; Xiao J
    Chemistry; 2013 Oct; 19(42):14187-93. PubMed ID: 24019056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine.
    Liu C; Zhang L; Cao L; Xiong Y; Ma Y; Cheng R; Ye J
    Commun Chem; 2022 May; 5(1):63. PubMed ID: 36697664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymmetric hydrogenation of di and trisubstituted enol phosphinates with N,P-ligated iridium complexes.
    Cheruku P; Diesen J; Andersson PG
    J Am Chem Soc; 2008 Apr; 130(16):5595-9. PubMed ID: 18370383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly Enantioselective Iridium-Catalyzed Hydrogenation of
    Wan YB; Hu XP
    Org Lett; 2022 Aug; 24(31):5797-5801. PubMed ID: 35912453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enantioselective hydrogenation of alpha-aryloxy and alpha-alkoxy alpha,beta-unsaturated carboxylic acids catalyzed by chiral spiro iridium/phosphino-oxazoline complexes.
    Li S; Zhu SF; Xie JH; Song S; Zhang CM; Zhou QL
    J Am Chem Soc; 2010 Jan; 132(3):1172-9. PubMed ID: 20047323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones.
    Noyori R; Ohkuma T
    Angew Chem Int Ed Engl; 2001 Jan; 40(1):40-73. PubMed ID: 11169691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iridium-Catalyzed Asymmetric Hydrogenation of Simple Ketones with Tridentate PNN Ligands Bearing Unsymmetrical Vicinal Diamines.
    Zhang L; Liu C; Sun M; Liang C; Cao L; Yao X; Ma Y; Cheng R; Ye J
    J Org Chem; 2023 Mar; 88(5):2942-2951. PubMed ID: 36787380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iridium/
    Wang Z; Zhao X; Wang S; Huang A; Wang Y; He J; Ling F; Zhong W
    Org Biomol Chem; 2021 Nov; 19(44):9746-9751. PubMed ID: 34730165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Readily Accessible and Highly Efficient Ferrocene-Based Amino-Phosphine-Alcohol (f-Amphol) Ligands for Iridium-Catalyzed Asymmetric Hydrogenation of Simple Ketones.
    Yu J; Duan M; Wu W; Qi X; Xue P; Lan Y; Dong XQ; Zhang X
    Chemistry; 2017 Jan; 23(4):970-975. PubMed ID: 27862426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A modular design of ruthenium catalysts with diamine and BINOL-derived phosphinite ligands that are enantiomerically-matched for the effective asymmetric transfer hydrogenation of simple ketones.
    Guo R; Elpelt C; Chen X; Song D; Morris RH
    Chem Commun (Camb); 2005 Jun; (24):3050-2. PubMed ID: 15959581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asymmetric hydrogenation of aromatic ketones catalyzed by the TolBINAP/DMAPEN-ruthenium(II) complex: a significant effect of N-substituents of chiral 1,2-diamine ligands on enantioselectivity.
    Ooka H; Arai N; Azuma K; Kurono N; Ohkuma T
    J Org Chem; 2008 Nov; 73(22):9084-93. PubMed ID: 18925787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Ferrocene-Based Diamine-Phosphine-Sulfonamide Ligands for Iridium-Catalyzed Asymmetric Hydrogenation of Ketones.
    Ling F; Nian S; Chen J; Luo W; Wang Z; Lv Y; Zhong W
    J Org Chem; 2018 Sep; 83(18):10749-10761. PubMed ID: 30064225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly enantioselective hydrogenation of steric hindrance enones catalyzed by Ru complexes with chiral diamine and achiral phosphane.
    Chen X; Zhou H; Zhang K; Li J; Huang H
    Org Lett; 2014 Aug; 16(15):3912-5. PubMed ID: 25054610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in osmium-catalyzed hydrogenation and dehydrogenation reactions.
    Chelucci G; Baldino S; Baratta W
    Acc Chem Res; 2015 Feb; 48(2):363-79. PubMed ID: 25650714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymmetric hydrogenation of imines and olefins using phosphine-oxazoline iridium complexes as catalysts.
    Trifonova A; Diesen JS; Andersson PG
    Chemistry; 2006 Mar; 12(8):2318-28. PubMed ID: 16363009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steering Asymmetric Lewis Acid Catalysis Exclusively with Octahedral Metal-Centered Chirality.
    Zhang L; Meggers E
    Acc Chem Res; 2017 Feb; 50(2):320-330. PubMed ID: 28128920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chiral phosphine-phosphoramidite ligands for highly efficient Ir-catalyzed asymmetric hydrogenation of sterically hindered N-arylimines.
    Hou CJ; Wang YH; Zheng Z; Xu J; Hu XP
    Org Lett; 2012 Jul; 14(13):3554-7. PubMed ID: 22738310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymmetric Transfer Hydrogenation of Arylketones Catalyzed by Enantiopure Ruthenium(II)/Pybox Complexes Containing Achiral Phosphonite and Phosphinite Ligands.
    Claros M; de Julián E; Díez J; Lastra E; Gamasa MP
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32102166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.